Mi Lan Kang

Title: Mi Lan Kang: Innovator in Biocompatible Drug Delivery Systems

Introduction

Mi Lan Kang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biocompatible drug delivery systems, particularly in the treatment of bone diseases. His innovative approach combines advanced materials with therapeutic agents to enhance treatment efficacy.

Latest Patents

Mi Lan Kang holds a patent for "Kartogenin-conjugated chitosan particles with improved sustained release property and biocompatibility." This invention focuses on kartogenin-conjugated chitosan particles that exhibit enhanced sustained release properties and biocompatibility. The patent demonstrates the effectiveness of these microparticles and nanoparticles in promoting chondrogenic differentiation and improving retention time in joints. This advancement enables targeted treatment for the prevention or treatment of bone diseases through a more fundamental approach.

Career Highlights

Mi Lan Kang is affiliated with the Dongguk University Industry-Academy Cooperation Foundation. His work at this institution emphasizes the collaboration between academia and industry, fostering innovation and practical applications of research findings. His dedication to advancing medical technology is evident in his research and patent contributions.

Collaborations

Mi Lan Kang collaborates with Gun Il Im, who is also involved in research related to biocompatible materials and drug delivery systems. Their partnership enhances the potential for innovative solutions in the medical field.

Conclusion

Mi Lan Kang's work exemplifies the intersection of innovation and practical application in the medical field. His contributions to biocompatible drug delivery systems are paving the way for more effective treatments for bone diseases.